The risks of doing so including infection, incorrect dosing, and adverse reactions without medical support are substantial
Ultimately, the choice between Cagrilintide vs Survodutide will be dictated by your specific research objectives
The patients comfort level, age, sex, physique, and health goals may also determine the injection location
The reason is that 9 out of 10 times, peptides in a pre-mixed liquid form will not be effective due to the instability and potential degradation during transport
There is no hard minimum, but practical considerations set a floor
Your protocol, your timeline, ongoing support all managed in one place